Alexandra Fuchs
French Alternative Energies and Atomic Energy Commission
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alexandra Fuchs.
Lab on a Chip | 2006
Alexandra Fuchs; Aldo Romani; Delphine Freida; Gianni Medoro; Mélanie Abonnenc; Luigi Altomare; Isabelle Chartier; Dorra Guergour; Christian L. Villiers; Patrice N. Marche; Marco Tartagni; Roberto Guerrieri; Francois Chatelain; Nicolò Manaresi
Sorting and recovering specific live cells from samples containing less than a few thousand cells have become major hurdles in rare cell exploration such as stem cell research, cell therapy and cell based diagnostics. We describe here a new technology based on a microelectronic chip integrating an array of over 100,000 independent electrodes and sensors which allow individual and parallel single cell manipulation of up to 10,000 cells while maintaining viability and proliferation capabilities. Manipulation is carried out using dynamic dielectrophoretic traps controlled by an electronic interface. We also demonstrate the capabilities of the chip by sorting and recovering individual live fluorescent cells from an unlabeled population.
Biochimica et Biophysica Acta | 1996
Alexandra Fuchs; Marie-Claire Dagher; Julien Faure; Pierre V. Vignais
Activation of the superoxide-generating NADPH-oxidase in phagocytic cells requires the assembly of a membrane-bound flavocytochrome b and cytosolic factors p47phox and p67phox under the control of the GTP-binding protein, Rac. A novel cytosolic component p40phox was recently identified. Most of the components of the complex contain SH3 domains and/or polyproline motifs which are likely to mediate protein-protein interactions occurring in the formation of the active NADPH-complex. The two-hybrid system was used to explore associations between the cytosolic factors. Various constructs of p47phox, p67phox and p40phox cDNAs coding for functional domains were inserted into two-hybrid system vectors, expressing fusion proteins either with the DNA binding protein Lex A or with the activation domain of Gal 4. The site of interaction of p67phox with p47phox was restricted to the C-terminal SH3 domain of p67phox and to the polyproline motif of p47phox. The polyproline motif of p47phox was also found to mediate interaction with the SH3 domain of p40phox, as well as intramolecular interaction within p47phox. The site of interation of p67phox with p40phox was found to be in the 150 amino acid stretch between the two SH3 domains of p67phox. As the C-terminal tail of p40phox which interacts with p67phox contains neither a SH3 domain nor a polyproline consensus site, it is concluded that a novel type of interaction occurs between p40phox and p67phox. Taken together, the results of the two-hybrid experiments led us to formulate a model for oxidase activation, induced by phosphorylation, in which p40phox tends to prevent spontaneous activation.
Nanoscale | 2016
Mireille Chevallet; Benoit Gallet; Alexandra Fuchs; Pierre-Henri Jouneau; K. Um; Elisabeth Mintz; Isabelle Michaud-Soret
Increased production and use of zinc oxide nanoparticles (ZnO-NPs) in consumer products has prompted the scientific community to investigate their potential toxicity, and understand their impact on the environment and organisms. Molecular mechanisms involved in ZnO-NP toxicity are still under debate and focus essentially on high dose expositions. In our study, we chose to evaluate the effect of sub-toxic doses of ZnO-NPs on human hepatocytes (HepG2) with a focus on metal homeostasis and redox balance disruptions. We showed massive dissolution of ZnO-NPs outside the cell, transport and accumulation of zinc ions inside the cell but no evidence of nanoparticle entry, even when analysed by high resolution TEM microscopy coupled with EDX. Gene expression analysis highlighted zinc homeostasis disruptions as shown by metallothionein 1X and zinc transporter 1 and 2 (ZnT1, ZnT2) over-expression. Major oxidative stress response genes, such as superoxide dismutase 1, 2 and catalase were not induced. Phase 2 enzymes in term of antioxidant response, such as heme oxygenase 1 (HMOX1) and the regulating subunit of the glutamate-cysteine ligase (GCLM) were slightly upregulated, but these observations may be linked solely to metal homeostasis disruptions, as these actors are involved in both metal and ROS responses. Finally, we observed abnormal mitochondria morphologies and autophagy vesicles in response to ZnO-NPs, indicating a potential role of mitochondria in storing and protecting cells from zinc excess but ultimately causing cell death at higher doses.
Proceedings of SPIE | 2004
Isabelle Chartier; Cécile Bory; Alexandra Fuchs; Delphine Freida; Nicolò Manaresi; Jacqueline Bablet; Karine Gilbert; Nicolas Sarrut; Francois Baleras; Christian L. Villiers; Laurent Fulbert
During the last decade, world-wide developments in micro-fabrication technologies have led to numerous Lab-On-a-Chip (LOC) micro-systems covering a wide spectrum of biotechnological applications. Although early LOC developments were driven by glass and silicon micro-fabrication techniques, in recent years polymeric-based LOC have been intensively developed. Taking advantage of each material, a hybrid device associating an active silicon chip with a passive polymeric micro-part has been developed to produce an addressable Cell-chip for individual cell manipulation and sorting. The complete hybrid micro-fluidic device fabrication is described here, including polymer structuring, hermetical sealing, biocompatibility studies, and fluidic interconnections with the sample as well as detection aspects. The cell manipulation is based on dielectrophoresis, which allows cell motion without fluid flow. First biological results will be presented.
Journal of Visualized Experiments | 2010
Sébastien Degot; Muriel Auzan; Violaine Chapuis; Anne Béghin; Amélie Chadeyras; Constantin Nelep; Maria Luisa Calvo-Muñoz; Joanne Young; Francois Chatelain; Alexandra Fuchs
To date, most HCA (High Content Analysis) studies are carried out with adherent cell lines grown on a homogenous substrate in tissue-culture treated micro-plates. Under these conditions, cells spread and divide in all directions resulting in an inherent variability in cell shape, morphology and behavior. The high cell-to-cell variance of the overall population impedes the success of HCA, especially for drug development. The ability of micropatterns to normalize the shape and internal polarity of every individual cell provides a tremendous opportunity for solving this critical bottleneck (1-2). To facilitate access and use of the micropatterning technology, CYTOO has developed a range of ready to use micropatterns, available in coverslip and microwell formats. In this video article, we provide detailed protocols of all the procedures from cell seeding on CYTOOchip micropatterns, drug treatment, fixation and staining to automated acquisition, automated image processing and final data analysis. With this example, we illustrate how micropatterns can facilitate cell-based assays. Alterations of the cell cytoskeleton are difficult to quantify in cells cultured on homogenous substrates, but culturing cells on micropatterns results in a reproducible organization of the actin meshwork due to systematic positioning of the cell adhesion contacts in every cell. Such normalization of the intracellular architecture allows quantification of even small effects on the actin cytoskeleton as demonstrated in these set of protocols using blebbistatin, an inhibitor of the actin-myosin interaction.
Biochimica et Biophysica Acta | 2017
Mireille Chevallet; Giulia Veronesi; Alexandra Fuchs; Elisabeth Mintz; Isabelle Michaud-Soret; Aurélien Deniaud
BACKGROUND The use of nanomaterials is constantly increasing in electronics, cosmetics, food additives, and is emerging in advanced biomedical applications such as theranostics, bio-imaging and therapeutics. However their safety raises concerns and requires appropriate methods to analyze their fate in vivo. SCOPE OF REVIEW In this review, we describe the current knowledge about the toxicity of labile metal (ZnO, CuO and Ag) nanoparticles (NPs) both at the organism and cellular levels, and describe the pathways that are triggered to maintain cellular homeostasis. We also describe advanced elemental imaging approaches to analyze intracellular NP fate. Finally, we open the discussion by presenting recent developments in terms of synthesis and applications of Ag and CuO NPs. MAJOR CONCLUSIONS Labile metal nanoparticles (MeNPs) release metal ions that trigger a cellular response involving biomolecules binding to the ions followed by regulation of the redox balance. In addition, specific mechanisms are set up by the cell in response to physiological ions such as Cu(I) and Zn(II). Among all types of NPs, labile MeNPs induce the strongest inflammatory responses which are most probably due to the combined effects of the NPs and of its released ions. Interestingly, recent developments in imaging technologies enable the intracellular visualization of both the NPs and their ions and promise new insights into nanoparticle fate and toxicity. GENERAL SIGNIFICANCE The exponential use of nanotechnologies associated with the difficulties of assessing their impact on health and the environment has prompted scientists to develop novel methodologies to characterize these nanoobjects in a biological context.
Electrophoresis | 1998
Mireille Chevallet; Véronique Santoni; Alexandra Poinas; David Rouquié; Alexandra Fuchs; Sylvie Kieffer; Joël Lunardi; Jérôme Garin; Thierry Rabilloud
Archive | 2003
Francois Chatelain; Yves Fouillet; Brigitte Fouque; Alexandra Fuchs; Béatrice Schaack
Archive | 2003
Alexandra Fuchs; Michel Heitzmann; Françoise Vinet
FEBS Journal | 1996
Jutta Wölfl; Marie Claire Dagher; Alexandra Fuchs; Miklós Geiszt; Erzsébet Ligeti